Home News Discover the latest breakthroughs, stories, and updates from Oncode Institute’s mission to outsmart cancer. Search Category Category Blog Post External Events Funding Research news Our Team press news In memoriam: David Morse Livingston, MD 21 Oct 2021 New research uncovers growth dynamics of pancreatic cancer 20 Oct 2021 Oncode Institute supports new preclinical collaboration between HepaRegeniX and the NKI 19 Oct 2021 “I need to know that what I do matters” 12 Oct 2021 Two Oncode researchers win the International Birnstiel Award 1 Oct 2021 Science meets forest in the heart of the Netherlands: highlights of Oncode’s first Postdoc Retreat 30 Sep 2021 History of successful STRIP consortium published in Nature Biotechnology 28 Sep 2021 Paving the way for treatment of AML patients with EVI1 gene expression 28 Sep 2021 Evidence for safety: stem cell transplants do not lead to changes in the DNA 7 Sep 2021 Oncode Institute co-lead of major consortium studying therapy resistance in cancer 1 Sep 2021 New research reveals that the actionable metastatic cancer genome is remarkably stable 9 Aug 2021 Absence of stem cells in pancreas changes view on pancreatic cancer 5 Aug 2021 Antibodies with a mission: what the Utrecht Monoclonal Antibody Facility (UMab) can do for you 27 Jul 2021 Oncode collaboration results in a new mathematical method that can predict cancer survival based on genetic changes 20 Jul 2021 Oncode Investigators Hugo Snippert and Jarno Drost receive NWO-Vidi grant 14 Jul 2021 Oncode and NKI spinout a new company targeting senescence in oncology, led by Rene Bernards 12 Jul 2021 Pagination Previous page ‹ … Page 14 Page 15 Page 16 Page 17 Current page 18 Page 19 Page 20 Page 21 Page 22 … Next page ›
Science meets forest in the heart of the Netherlands: highlights of Oncode’s first Postdoc Retreat 30 Sep 2021
Antibodies with a mission: what the Utrecht Monoclonal Antibody Facility (UMab) can do for you 27 Jul 2021
Oncode collaboration results in a new mathematical method that can predict cancer survival based on genetic changes 20 Jul 2021
Oncode and NKI spinout a new company targeting senescence in oncology, led by Rene Bernards 12 Jul 2021
